The next RxDC report is due by June 1, 2024. To meet the requirement, we will follow the same process as last year and file on behalf of our fully insured and ASO clients for the benefits we administe...
Please join Anthem for a half-hour webinar on Tuesday, February 13, 2024, at 3 p.m. ET / noon PT
Anthem's panel of experts will discuss how their gene therapy solution supports the health of your emp...
Smile Direct Club, one of our national providers in our Ortho@Home program, closed its business and shut down global operations on December 8, 2023 — a few months after the teeth-straightening company...
The new regulations went into effect on January 1, 2024 and mandate changes to claims processed for members residing in Florida, Arkansas, Oklahoma, Tennessee, and West Virginia, regardless of where t...
The Broker Academy is back with a full slate of training opportunities for you and your staff this year, and we’ll be adding more throughout the year. Register now for the first training of 2024.
W...
Anthem’s new 2024 Specialty Broker Bonus Program will begin February 1, 2024. The new broker bonus program includes dental, vision, and supplemental health products. It excludes life and disability p...
Anthem’s health and wellness programs focus on employers’ top concerns, including behavioral health, maternity, and program engagement. Anthem leverages a whole-heath approach to wellness with integra...
On December 22, 2023, Anthem submitted Gag Clause Prohibition Compliance Attestations on behalf of their fully insured clients for the benefits they administer and maintain. ASO clients who completed ...
Anthem invites you to join a half-hour webinar on Tuesday, January 16, 2024, at 1 p.m. ET/10 a.m. PT as Executive Vice President of Commercial and Specialty business, Morgan Kendrick, discusses Anthem...
Avoid disruption of your commission payments! Effective November 1, 2023, Anthem agents must have an active license and any state-required appointment.
Anthem's CarelonRx will add Humira biosimilar drugs to its commercial formularies on December 1, 2023.
Adalimumab-adbm (lower list price version) will be added to all CarelonRx commercial formularies...